Invention Grant
- Patent Title: Arginine derivatives with NP-1 antagonistic activity
- Patent Title (中): 具有NP-1拮抗活性的精氨酸衍生物
-
Application No.: US13361134Application Date: 2012-01-30
-
Publication No.: US08227606B2Publication Date: 2012-07-24
- Inventor: Haiyan Jia , Ian Zachary , Michelle Tickner , Lili Cheng , Chris Chapman , Katie Ellard , Basil Hartzoulakis , Ashley Jarvis , Rosemary Lynch , Jamie Nally , David Selwood , Mark Stewart
- Applicant: Haiyan Jia , Ian Zachary , Michelle Tickner , Lili Cheng , Chris Chapman , Katie Ellard , Basil Hartzoulakis , Ashley Jarvis , Rosemary Lynch , Jamie Nally , David Selwood , Mark Stewart
- Applicant Address: GB London
- Assignee: Ark Therapeutics, Ltd.
- Current Assignee: Ark Therapeutics, Ltd.
- Current Assignee Address: GB London
- Agency: Pharmaceutical Patent Atty's, LLC
- Priority: GB0619611.7 20061004
- Main IPC: C07D417/14
- IPC: C07D417/14
Abstract:
The present invention is a compound of formula (I) or formula (II) which are suitable as NP-1 antagonists.
Public/Granted literature
- US20120122862A1 ARGININE DERIVATIVES WITH NP-I ANTAGONISTIC ACTIVITY Public/Granted day:2012-05-17
Information query
